Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 05, 2022

SELL
$193.69 - $247.03 $222,743 - $284,084
-1,150 Closed
0 $0
Q2 2021

Jul 06, 2021

BUY
$155.9 - $187.99 $179,285 - $216,188
1,150 New
1,150 $214,000
Q2 2019

Jul 12, 2019

SELL
$97.98 - $114.28 $291,490 - $339,983
-2,975 Closed
0 $0
Q4 2018

Jan 25, 2019

SELL
$79.28 - $95.27 $3,964 - $4,763
-50 Reduced 1.65%
2,975 $255,000
Q1 2018

Apr 16, 2018

SELL
$71.51 - $84.69 $227,044 - $268,890
-3,175 Reduced 51.21%
3,025 $253,000
Q4 2017

Jan 29, 2018

BUY
$63.24 - $72.8 $392,088 - $451,360
6,200
6,200 $468,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Stonebridge Capital Management Inc Portfolio

Follow Stonebridge Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Management Inc with notifications on news.